Literature DB >> 30564695

Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care.

Rhona Eveleigh1, Esther Muskens2, Peter Lucassen3, Peter Verhaak4,5, Jan Spijker6,7, Chris van Weel8,9, Richard Oude Voshaar10,11, Anne Speckens10.   

Abstract

BACKGROUND: Antidepressant use has increased exponentially in recent decades, mostly due to long continuation. AIM: To assess the effectiveness of a tailored recommendation to withdraw antidepressant treatment. DESIGN &
SETTING: Randomised controlled trial in primary care (PANDA study) in the Netherlands.
METHOD: Long-term antidepressant users (≥9 months) were selected from GPs prescription databases. Patients were diagnosed with the Composite International Diagnostic Interview (CIDI). Long-term users without indication for maintenance treatment (overtreatment) were selected. The intervention consisted of disclosure of the current psychiatric diagnosis combined with a tailored treatment recommendation. Patients were followed for 12 months.
RESULTS: The study included 146 participants from 45 family practices. Of the 70 patients in the intervention group, 34 (49%) did not comply with the advice to stop their antidepressant medication. Of the 36 (51%) patients who agreed to try, only 4 (6%) succeeded. These figures were consistent with the control group, where 6 (8%) of the 76 patients discontinued antidepressant use successfully. Patients who were recommended to discontinue their antidepressant medication reported a higher relapse rate than the control group (26% versus 13%, P = 0.05).
CONCLUSION: Changing inappropriate long-term antidepressant use is difficult.

Entities:  

Keywords:  antidepressant agents; anxiety disorder; depressive disorder; general practice; inappropriate prescribing; primary care

Year:  2017        PMID: 30564695      PMCID: PMC6181099          DOI: 10.3399/bjgpopen17X101265

Source DB:  PubMed          Journal:  BJGP Open        ISSN: 2398-3795


  32 in total

1.  Why can't GPs follow guidelines on depression? We must question the basis of the guidelines themselves.

Authors:  T Kendrick
Journal:  BMJ       Date:  2000-01-22

Review 2.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

3.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

4.  Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).

Authors:  Ronald C Kessler; Jamie Abelson; Olga Demler; Javier I Escobar; Miriam Gibbon; Margaret E Guyer; Mary J Howes; Robert Jin; William A Vega; Ellen E Walters; Philip Wang; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

Review 5.  Managing depression in primary care.

Authors:  N Freemantle; F Song; T A Sheldon; P Watson; J M Mason; A F Long
Journal:  Qual Health Care       Date:  1993-03

6.  Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study.

Authors:  Wim J M J Gorgels; Richard C Oude Voshaar; Audrey J J Mol; Eloy H van de Lisdonk; Anton J L M van Balkom; Henk J M van den Hoogen; Jan Mulder; Marinus H M Breteler; Frans G Zitman
Journal:  Drug Alcohol Depend       Date:  2005-04-04       Impact factor: 4.492

7.  Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.

Authors:  Bruce Arroll; Steve Macgillivray; Simon Ogston; Ian Reid; Frank Sullivan; Brian Williams; Iain Crombie
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

8.  Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  Jan Spijker; Ron de Graaf; Rob V Bijl; Aartjan T F Beekman; Johan Ormel; Willem A Nolen
Journal:  Br J Psychiatry       Date:  2002-09       Impact factor: 9.319

9.  Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial.

Authors:  R C Oude Voshaar; W J M J Gorgels; A J J Mol; A J L M van Balkom; E H van de Lisdonk; M H M Breteler; H J M van den Hoogen; F G Zitman
Journal:  Br J Psychiatry       Date:  2003-06       Impact factor: 9.319

10.  Incidence and determinants of long-term use of antidepressants.

Authors:  Welmoed E E Meijer; E R Heerdink; Hubert G M Leufkens; Ron M C Herings; Antoine C G Egberts; Willem A Nolen
Journal:  Eur J Clin Pharmacol       Date:  2004-02-19       Impact factor: 2.953

View more
  9 in total

1.  The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.

Authors:  Anne Guy; Marion Brown; Stevie Lewis; Mark Horowitz
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-09

2.  Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Authors:  Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

Review 3.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

4.  Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators.

Authors:  Rhona Eveleigh; Anne Speckens; Chris van Weel; Richard Oude Voshaar; Peter Lucassen
Journal:  Ther Adv Psychopharmacol       Date:  2019-09-03

5.  Effectiveness of a brief psychological mindfulness-based intervention for the treatment of depression in primary care: study protocol for a randomized controlled clinical trial.

Authors:  Alba Lopez-Montoyo; Soledad Quero; Jesus Montero-Marin; Alberto Barcelo-Soler; Maria Beltran; Daniel Campos; Javier Garcia-Campayo
Journal:  BMC Psychiatry       Date:  2019-10-16       Impact factor: 3.630

6.  Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study.

Authors:  Carlotta Lunghi; Ippazio Cosimo Antonazzo; Sofia Burato; Emanuel Raschi; Violetta Zoffoli; Emanuele Forcesi; Elisa Sangiorgi; Marco Menchetti; Pasquale Roberge; Elisabetta Poluzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-07       Impact factor: 2.570

7.  Long-term antidepressant use in general practice: a qualitative study of GPs' views on discontinuation.

Authors:  Maria Donald; Riitta Partanen; Leah Sharman; Johanna Lynch; Genevieve A Dingle; Catherine Haslam; Mieke van Driel
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

8.  Antidepressant withdrawal - the tide is finally turning.

Authors:  Michael P Hengartner; James Davies; John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-22       Impact factor: 6.892

9.  Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers.

Authors:  Marloes J Huijbers; Carolien Wentink; Esther Simons; Jan Spijker; Anne Speckens
Journal:  BMJ Open       Date:  2020-11-11       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.